The contributions of PGI levels, PGI/PGII ratio, and CEA in the Positive‐Gastric‐GIST‐PG‐CEA model performance were 0.33, 0.15, and 0.13 based on SHAP analysis. The gene discussed is CEACAM5; the disease is gastrointestinal stromal tumor.